19th Dec 2017 7:00 am |
RNS |
Indivior amends and extends $534m debt facilities |
12th Dec 2017 7:00 am |
RNS |
Indivior's RBP-7000 NDA Accepted by FDA |
8th Dec 2017 7:00 am |
RNS |
Additional Listing |
1st Dec 2017 7:00 am |
RNS |
FDA Approves SUBLOCADE (TM) |
23rd Nov 2017 1:46 pm |
RNS |
Holding(s) in Company |
10th Nov 2017 4:02 pm |
RNS |
Block listing Interim Review |
6th Nov 2017 7:00 am |
RNS |
Jefferies London Healthcare Conference |
2nd Nov 2017 1:28 pm |
RNS |
Board Committee Changes |
2nd Nov 2017 11:40 am |
RNS |
Holding(s) in Company |
2nd Nov 2017 11:00 am |
RNS |
3rd Quarter Results |
1st Nov 2017 7:00 am |
RNS |
FDA Advisory Committees Vote to Approve RBP-6000 |
10th Oct 2017 7:00 am |
RNS |
Notice of Results |
9th Oct 2017 1:17 pm |
RNS |
Holding(s) in Company |
3rd Oct 2017 4:00 pm |
RNS |
FDA Posts Advisory Committee Notice for RBP-6000 |
2nd Oct 2017 7:00 am |
RNS |
RBP-7000 - Submission of NDA to U.S. FDA |
25th Sep 2017 7:00 am |
RNS |
Indivior settlement with Mylan Pharmaceuticals |
21st Sep 2017 3:36 pm |
RNS |
Holding(s) in Company |
21st Sep 2017 9:37 am |
RNS |
Holding(s) in Company |
15th Sep 2017 7:00 am |
RNS |
Indivior asserts new patent against ANDA-filers |
11th Sep 2017 9:50 am |
RNS |
Holding(s) in Company |
1st Sep 2017 3:04 pm |
RNS |
Total Voting Rights |
1st Sep 2017 7:00 am |
RNS |
Indivior to appeal court rulings ANDA litigation |
31st Aug 2017 5:21 pm |
RNS |
Holding(s) in Company |
30th Aug 2017 5:00 pm |
RNS |
Morgan Stanley Annual Global Healthcare Conference |
14th Aug 2017 7:00 am |
RNS |
Holding(s) in Company |
10th Aug 2017 4:36 pm |
RNS |
Director/PDMR Shareholding (Replacement) |
10th Aug 2017 4:00 pm |
RNS |
Director/PDMR Shareholding |
8th Aug 2017 11:24 am |
RNS |
Holding(s) in Company |
8th Aug 2017 11:16 am |
RNS |
Holding(s) in Company |
8th Aug 2017 11:14 am |
RNS |
Holding(s) in Company |
8th Aug 2017 11:10 am |
RNS |
Holding(s) in Company |
2nd Aug 2017 11:08 am |
RNS |
Holding(s) in Company |
1st Aug 2017 7:00 am |
RNS |
Total Voting Rights |
31st Jul 2017 3:58 pm |
RNS |
Holding(s) in Company |
31st Jul 2017 7:30 am |
RNS |
Indivior's NALSCUE® Receives ANSM MA for France |
31st Jul 2017 7:00 am |
RNS |
RBP-6000 NDA Receives FDA Priority Review |
27th Jul 2017 7:00 am |
RNS |
Half Year Financial Results |
13th Jul 2017 2:00 pm |
RNS |
Notice of Results |
29th Jun 2017 11:00 am |
RNS |
RBP-6000 Investor Event Reminder |
16th Jun 2017 2:00 pm |
RNS |
RBP-6000 Investor Event |